Crohn's Disease Clinical Trials in Guangzhou, Guangdong
10 recruitingGuangzhou, Guangdong, China
Showing 1–10 of 10 trials
Recruiting
Phase 3
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Crohn's Disease
Sanofi980 enrolled196 locationsNCT07184931
Recruiting
Phase 3
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Crohn's Disease
Merck Sharp & Dohme LLC1,200 enrolled499 locationsNCT06430801
Recruiting
Real-World Study of IL-23 Inhibitors in Active Crohn's Disease
Crohn's Disease
Sixth Affiliated Hospital, Sun Yat-sen University665 enrolled1 locationNCT07545317
Recruiting
Phase 3
Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease
Crohn's Disease
AbbVie110 enrolled83 locationsNCT06332534
Recruiting
Phase 2
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
Crohn's Disease
Takeda268 enrolled194 locationsNCT06233461
Recruiting
Exclusive Enteral Nutrition Therapy for Active and Complicated Crohn's Disease
Crohn's Disease
Sixth Affiliated Hospital, Sun Yat-sen University300 enrolled1 locationNCT07504510
Recruiting
Phase 3
A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
Crohn's Disease
AbbVie110 enrolled85 locationsNCT05995353
Recruiting
Phase 2
A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
Crohn's DiseaseUlcerative Colitis
Takeda183 enrolled16 locationsNCT06764615
Recruiting
Phase 3
A Study of Vedolizumab in Adult Participants With Moderate to Severe Crohn's Disease
Crohn's Disease
Takeda408 enrolled41 locationsNCT05837897
Recruiting
Efficacy and Safety of Upadacitinib in Inflammatory Bowel Disease
Crohn's DiseaseUlcerative ColitisInflammatory Bowel Disease
Xiang Gao174 enrolled6 locationsNCT06780683